|
US3076817A
(en)
*
|
|
1963-02-05 |
|
New j-amino-thiophene-z |
|
DE1055007B
(de)
|
1957-08-29 |
1959-04-16 |
Dr Hans Fiesselmann |
Verfahren zur Herstellung von 3-Aminothiophen-2-carbonsaeureestern und den entsprechenden freien Carbonsaeuren
|
|
US3470151A
(en)
*
|
1966-05-17 |
1969-09-30 |
Beecham Group Ltd |
Furyl- and thienyl-penicillins and salts thereof
|
|
AU518216B2
(en)
*
|
1977-09-06 |
1981-09-17 |
Hafslund Nycomed Pharma Aktiengesellschaft |
Thienothiazine derivatives
|
|
US4244205A
(en)
|
1978-04-25 |
1981-01-13 |
Wean United Inc. |
Apparatus for aligning extrusion producing members of a press
|
|
DD146952A1
(de)
|
1979-11-09 |
1981-03-11 |
Karl Gewald |
Verfahren zur herstellung von substituierten 3-amino-4-cyan-5-phenylthiophenen
|
|
JPS57116077A
(en)
|
1981-01-12 |
1982-07-19 |
Kanebo Ltd |
Thieno(3,2-b)pyridinecarboxylic acid derivative
|
|
GB8515207D0
(en)
*
|
1985-06-15 |
1985-07-17 |
Boots Co Plc |
Therapeutic agents
|
|
GB8627698D0
(en)
|
1986-11-20 |
1986-12-17 |
Boots Co Plc |
Therapeutic agents
|
|
DD263055A1
(de)
|
1987-07-28 |
1988-12-21 |
Univ Dresden Tech |
Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene
|
|
DE4023048A1
(de)
*
|
1990-07-20 |
1992-01-23 |
Basf Ag |
Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
|
|
JP2574085B2
(ja)
|
1991-10-28 |
1997-01-22 |
株式会社トクヤマ |
３−アミノ−２−チオフェンカルボン酸誘導体の製造方法
|
|
FR2689129B1
(fr)
|
1992-03-27 |
1995-05-12 |
Atochem Elf Sa |
Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
|
|
JPH0625221A
(ja)
|
1992-07-10 |
1994-02-01 |
Tokuyama Soda Co Ltd |
３−アミノ−２−チオフェンカルボン酸誘導体の製造方法
|
|
JPH0748360A
(ja)
|
1993-05-31 |
1995-02-21 |
Yoshitomi Pharmaceut Ind Ltd |
ビフェニルテトラゾール誘導体
|
|
EP0658559A1
(de)
*
|
1993-12-14 |
1995-06-21 |
Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. |
Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
|
|
DE19522603A1
(de)
*
|
1995-06-19 |
1997-01-09 |
Siemens Ag |
Schutzeinrichtung gegen Überlastung der Schaltkontakte eines Schaltgerätes
|
|
BR9606547A
(pt)
*
|
1995-08-02 |
1997-10-14 |
Uriach & Cia Sa J |
Novos derivados de pirimidona com atividade fungicida
|
|
BR9606546A
(pt)
*
|
1995-08-02 |
1998-07-14 |
Uriach & Cia Sa J |
Novas carboxamidas com atividade fungicida
|
|
KR100509388B1
(ko)
|
1996-10-18 |
2005-08-23 |
버텍스 파마슈티칼스 인코포레이티드 |
세린 프로테아제, 특히 간염 ｃ 바이러스 ｎｓ３ 프로테아제의 저해제
|
|
JP4000608B2
(ja)
*
|
1996-11-07 |
2007-10-31 |
トヨタ自動車株式会社 |
水素製造充填装置および電気自動車
|
|
TW523506B
(en)
*
|
1996-12-18 |
2003-03-11 |
Ono Pharmaceutical Co |
Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients
|
|
US6117911A
(en)
*
|
1997-04-11 |
2000-09-12 |
Neorx Corporation |
Compounds and therapies for the prevention of vascular and non-vascular pathologies
|
|
JP3455233B2
(ja)
|
1997-04-28 |
2003-10-14 |
テキサス・バイオテクノロジー・コーポレイシヨン |
エンドテリン介在障害治療用のスルホンアミド類
|
|
US5783705A
(en)
*
|
1997-04-28 |
1998-07-21 |
Texas Biotechnology Corporation |
Process of preparing alkali metal salys of hydrophobic sulfonamides
|
|
US6344476B1
(en)
*
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
|
ES2234144T3
(es)
|
1997-08-11 |
2005-06-16 |
Boehringer Ingelheim (Canada) Ltd. |
Analogos de peptidos inhibidores de la hepatitis c.
|
|
WO1999007733A2
(en)
|
1997-08-11 |
1999-02-18 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptides
|
|
CN1268949A
(zh)
*
|
1997-09-02 |
2000-10-04 |
吉富制药株式会社 |
稠合噻吩化合物及其医药用途
|
|
US6140351A
(en)
*
|
1997-12-19 |
2000-10-31 |
Berlex Laboratories, Inc. |
Ortho-anthranilamide derivatives as anti-coagulants
|
|
AU2003204708B2
(en)
|
1997-12-22 |
2006-05-25 |
Bayer Healthcare Llc |
Inhibition of Raf Kinase using Substituted Heterocyclic Ureas
|
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
US6291514B1
(en)
*
|
1998-02-09 |
2001-09-18 |
3-Dimensional Pharmaceuticals, Inc. |
Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
|
|
US20050119332A1
(en)
*
|
1998-03-12 |
2005-06-02 |
Lone Jeppesen |
Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases)
|
|
US6262044B1
(en)
*
|
1998-03-12 |
2001-07-17 |
Novo Nordisk A/S |
Modulators of protein tyrosine phosphatases (PTPASES)
|
|
US6214879B1
(en)
*
|
1998-03-24 |
2001-04-10 |
Virginia Commonwealth University |
Allosteric inhibitors of pyruvate kinase
|
|
US6689754B1
(en)
*
|
1998-04-10 |
2004-02-10 |
G. D. Searle & Co. |
Heterocyclic glycyl β-alanine derivatives
|
|
DE69903992T2
(de)
*
|
1998-04-15 |
2003-08-21 |
Pfizer Products Inc., Groton |
Heterocyclische Carboxamide
|
|
EP0960882A1
(en)
*
|
1998-05-19 |
1999-12-01 |
Hoechst Marion Roussel Deutschland GmbH |
Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists
|
|
US6858223B2
(en)
*
|
1998-06-23 |
2005-02-22 |
Altana Pharma Ag |
Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
|
|
ATE253061T1
(de)
*
|
1998-06-29 |
2003-11-15 |
Iaf Biochem Int |
Zur behandlung von krebs nützliche thiophen- und furan-2,5-dicarboxamide
|
|
WO2000006529A1
(en)
|
1998-07-27 |
2000-02-10 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti S.P.A. |
Diketoacid-derivatives as inhibitors of polymerases
|
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
US7101878B1
(en)
*
|
1998-08-20 |
2006-09-05 |
Agouron Pharmaceuticals, Inc. |
Non-peptide GNRH agents, methods and intermediates for their preparation
|
|
DE19903398A1
(de)
|
1999-01-29 |
2000-08-10 |
Hassan Jomaa |
Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen
|
|
US6492403B1
(en)
*
|
1999-02-09 |
2002-12-10 |
3-Dimensional Pharmaceuticals, Inc. |
Methods of treating C1s-mediated diseases and conditions and compositions thereof
|
|
ATE278674T1
(de)
*
|
1999-03-12 |
2004-10-15 |
Boehringer Ingelheim Pharma |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
|
JP2002539206A
(ja)
*
|
1999-03-12 |
2002-11-19 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての芳香族複素環化合物
|
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
|
JP2001010957A
(ja)
|
1999-04-28 |
2001-01-16 |
Sankyo Co Ltd |
肝障害の予防または抑制剤
|
|
DE19920247A1
(de)
|
1999-05-03 |
2000-11-16 |
Hassan Jomaa |
Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung
|
|
HN2000000051A
(es)
*
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
|
US6867217B1
(en)
*
|
1999-05-19 |
2005-03-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
|
GB9929552D0
(en)
*
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
CA2385972A1
(en)
|
1999-10-01 |
2001-04-12 |
Haruhisa Ogita |
Novel diarylamide derivatives and use thereof as medicines
|
|
BR0015909A
(pt)
*
|
1999-11-29 |
2002-08-06 |
Novartis Ag |
N-heteroaril alfa-alcoximino-carboxamidas pesticidas
|
|
NZ514403A
(en)
|
1999-12-27 |
2002-10-25 |
Japan Tobacco Inc |
Fused-ring compounds and use thereof as drugs
|
|
DE10002424A1
(de)
*
|
2000-01-20 |
2001-07-26 |
Siemens Ag |
Di(het)arylaminothiophen-Derivate
|
|
GB0003154D0
(en)
*
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
MY138097A
(en)
*
|
2000-03-22 |
2009-04-30 |
Du Pont |
Insecticidal anthranilamides
|
|
WO2001085172A1
(en)
|
2000-05-10 |
2001-11-15 |
Smithkline Beecham Corporation |
Novel anti-infectives
|
|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
JP2001354658A
(ja)
|
2000-06-15 |
2001-12-25 |
Taisho Pharmaceut Co Ltd |
ヒドロキシホルムアミジン化合物及びその塩並びにそれらを含む医薬
|
|
US6414013B1
(en)
*
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
US7105565B2
(en)
|
2000-11-08 |
2006-09-12 |
Syngenta Crop Protection, Inc. |
Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses
|
|
DE60119968T2
(de)
|
2000-11-20 |
2007-01-18 |
Bristol-Myers Squibb Co. |
Hepatitis c tripeptid inhibitoren
|
|
US7015223B1
(en)
*
|
2000-11-20 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
|
|
US6892279B2
(en)
*
|
2000-11-30 |
2005-05-10 |
Mosaid Technologies Incorporated |
Method and apparatus for accelerating retrieval of data from a memory system with cache by reducing latency
|
|
DE10061876A1
(de)
*
|
2000-12-12 |
2002-06-20 |
Aventis Pharma Gmbh |
Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
SK286630B6
(sk)
|
2001-01-22 |
2009-02-05 |
Merck & Co., Inc. |
Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
|
|
ATE497603T1
(de)
|
2001-03-02 |
2011-02-15 |
Gpc Biotech Ag |
Drei-hybrid-assaysystem
|
|
US20040102324A1
(en)
*
|
2002-02-28 |
2004-05-27 |
Annis Gary David |
Heterocyclic diamide invertebrate pest control agents
|
|
WO2002069903A2
(en)
|
2001-03-06 |
2002-09-12 |
Biocryst Pharmaceuticals, Inc. |
Nucleosides, preparation thereof and use as inhibitors of rna viral polymerases
|
|
US6734207B2
(en)
*
|
2001-04-20 |
2004-05-11 |
Parker Hughes Institute |
Cytotoxic compounds
|
|
EP1256628A3
(en)
|
2001-05-10 |
2003-03-19 |
Agouron Pharmaceuticals, Inc. |
Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
|
|
US6713638B2
(en)
*
|
2001-05-18 |
2004-03-30 |
Joel M. Linden |
2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors
|
|
AR036081A1
(es)
|
2001-06-07 |
2004-08-11 |
Smithkline Beecham Corp |
Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
|
|
WO2002100846A1
(en)
|
2001-06-11 |
2002-12-19 |
Shire Biochem Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
US6881741B2
(en)
*
|
2001-06-11 |
2005-04-19 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
SE0102102D0
(sv)
*
|
2001-06-13 |
2001-06-13 |
Hoeganaes Ab |
High density stainless steel products and method for the preparation thereof
|
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
|
SE0102617D0
(sv)
*
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
SE0102616D0
(sv)
*
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
US6689854B2
(en)
|
2001-08-23 |
2004-02-10 |
3M Innovative Properties Company |
Water and oil repellent masonry treatments
|
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するＲｈｏキナーゼ阻害剤
|
|
US6924276B2
(en)
*
|
2001-09-10 |
2005-08-02 |
Warner-Lambert Company |
Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
|
|
WO2003026587A2
(en)
|
2001-09-26 |
2003-04-03 |
Bristol-Myers Squibb Company |
Compounds useful for treating hepatitus c virus
|
|
EP1448545B1
(en)
*
|
2001-10-04 |
2008-11-19 |
Smithkline Beecham Corporation |
Nf-kb inhibitors
|
|
US7285557B2
(en)
*
|
2001-10-15 |
2007-10-23 |
Smithkline Beecham P.L.C. |
Pyrimidinones as melanin concentrating hormone receptor 1
|
|
US7220777B2
(en)
*
|
2001-10-15 |
2007-05-22 |
Smithkline Beecham P.L.C. |
Lactam derivatives as antagonists for human 11cby receptors
|
|
US7241796B2
(en)
|
2001-10-24 |
2007-07-10 |
Vertex Pharmaceuticals Inc. |
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
|
|
TWI281916B
(en)
*
|
2001-10-25 |
2007-06-01 |
Lilly Co Eli |
Antitumor compounds and methods
|
|
AU2002352443A1
(en)
*
|
2001-12-21 |
2003-07-15 |
Consejo Superior De Investigaciones Cientificas |
Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3
|
|
US6835745B2
(en)
*
|
2002-01-15 |
2004-12-28 |
Wyeth |
Phenyl substituted thiophenes as estrogenic agents
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
KR20040099425A
(ko)
|
2002-04-11 |
2004-11-26 |
버텍스 파마슈티칼스 인코포레이티드 |
세린 프로테아제, 특히 ｃ형 간염 바이러스 ｎｓ3-ｎｓ4프로테아제의 억제제
|
|
US7138530B2
(en)
*
|
2002-05-28 |
2006-11-21 |
3-Dimensional Pharmaceuticals, Inc. |
Thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
|
|
US7179836B2
(en)
*
|
2002-09-20 |
2007-02-20 |
Smithkline Beecham Corporation |
Chemical compounds
|
|
CN1155679C
(zh)
|
2002-09-20 |
2004-06-30 |
华南理工大学 |
含低聚噻吩骨格的液晶化合物及其制备方法
|
|
US20050075331A1
(en)
*
|
2003-10-06 |
2005-04-07 |
Pratt John K. |
Anti-infective agents
|
|
US7902203B2
(en)
*
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
|
US20040162285A1
(en)
*
|
2002-11-01 |
2004-08-19 |
Pratt John K. |
Anti-infective agents
|
|
EP2361913A1
(en)
|
2002-11-01 |
2011-08-31 |
Abbott Laboratories |
Anti-infective agents
|
|
US20040097492A1
(en)
*
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
|
DE10253220A1
(de)
*
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
MXPA05006196A
(es)
*
|
2002-12-10 |
2006-01-27 |
Virochem Pharma Inc |
Compuestos y metodos para el tratamiento o prevencion de infecciones por flavivirus.
|
|
US20040192707A1
(en)
|
2002-12-10 |
2004-09-30 |
Laval Chan Chun Kong |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
|
KR101058696B1
(ko)
|
2002-12-10 |
2011-08-22 |
바이로켐 파마 인코포레이티드 |
후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법
|
|
US7098241B2
(en)
*
|
2002-12-16 |
2006-08-29 |
Hoffmann-La Roche Inc. |
Thiophene hydroxamic acid derivatives
|
|
US7196114B2
(en)
*
|
2003-02-17 |
2007-03-27 |
Sanofi-Aventis Deutschland Gmbh |
Substituted 3-(benzoylureido) thiophene derivatives, processes for preparing them and their use
|
|
JP2006526011A
(ja)
|
2003-04-11 |
2006-11-16 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ（特に、ｈｃｖｎｓ３−ｎｓ４ａプロテアーゼ）のインヒビター
|
|
WO2004092161A1
(en)
|
2003-04-11 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
CN1852920B
(zh)
|
2003-07-18 |
2010-12-15 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶抑制剂、特别是hcv ns3-ns4a蛋白酶抑制剂
|
|
TWI359147B
(en)
|
2003-09-05 |
2012-03-01 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hcv n
|
|
EP1664091A1
(en)
|
2003-09-18 |
2006-06-07 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
TW200512181A
(en)
*
|
2003-09-26 |
2005-04-01 |
Tanabe Seiyaku Co |
Amide-type carboxamide derivatives
|
|
DE10359791A1
(de)
*
|
2003-12-19 |
2005-07-21 |
Bayer Healthcare Ag |
Substituierte Thiophene
|
|
CN1938332B
(zh)
|
2004-02-04 |
2011-10-19 |
沃泰克斯药物股份有限公司 |
丝氨酸蛋白酶、特别是hcv ns3-ns4a蛋白酶的抑制剂
|
|
WO2005092863A1
(en)
*
|
2004-03-26 |
2005-10-06 |
Smithkline Beecham Corporation |
4-carbox pyrazole derivates useful as anti-viral agents
|
|
WO2005095386A1
(en)
*
|
2004-03-30 |
2005-10-13 |
Chiron Corporation |
Substituted thiophene derivatives as anti-cancer agents
|
|
WO2006019831A1
(en)
|
2004-07-14 |
2006-02-23 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
RU2007116265A
(ru)
|
2004-10-01 |
2008-11-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Ингибирование протеазы ns3-ns4a вируса hcv
|
|
DE102004061746A1
(de)
*
|
2004-12-22 |
2006-07-06 |
Bayer Healthcare Ag |
Alkinyl-substituierte Thiophene
|
|
DE102005028077A1
(de)
*
|
2004-12-22 |
2006-07-13 |
Aicuris Gmbh & Co. Kg |
Alkinyl-substituierte Thiophene
|
|
WO2006119646A1
(en)
|
2005-05-13 |
2006-11-16 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
|
CA2617042A1
(en)
*
|
2005-07-29 |
2007-02-01 |
Takeda Pharmaceutical Company Limited |
Spiro-cyclic compound
|